Latest news with #BrandonWalker
Associated Press
20-04-2025
- Business
- Associated Press
NEWMONT ALERT: Bragar Eagel & Squire, P.C. is Investigating Newmont Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Newmont Corporation (NYSE:NEM) on behalf of long-term stockholders following a class action complaint that was filed against Newmont on January 31, 2025 with a Class Period from February 22, 2024 to October 23, 2024. Our investigation concerns whether the board of directors of Newmont have breached their fiduciary duties to the company. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) defendants created the false impression that they possessed reliable information pertaining to Newmont's projected revenue outlook and ability to deliver growing gold and mineral production at its Tier 1 portfolio operations through mining and cost profile improvements; and (2) defendants provided the public with materially flawed statements of confidence and growth projections which did not account for these variables. If you are a long-term stockholder of Newmont, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Marion Passmore, Esq. (212) 355-4648 [email protected]
Associated Press
20-04-2025
- Business
- Associated Press
COMPASS MINERALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Compass Minerals International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, April 19, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. (NYSE: CMP) on behalf of long-term stockholders following a class action complaint that was filed against Compass Minerals on April 24, 2024 with a Class Period from November 29, 2023 to March 22, 2024. Our investigation concerns whether the board of directors of Compass Minerals have breached their fiduciary duties to the company. According to the filed complaint, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Compass Minerals overstated the likelihood that it would be awarded a renewed U.S. Forest Service contract for the use of its proprietary magnesium chloride-based aerial fire retardants for the 2024 fire season, as a result of safety issues presented by its fire retardant; (2) Compass Minerals materially overstated the extent to which testing had confirmed that its fire retardants were safe; and (3) as a result, defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times. If you are a long-term stockholder of Compass Minerals, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Marion Passmore, Esq. (212) 355-4648 [email protected]
Associated Press
19-04-2025
- Business
- Associated Press
IBOTTA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ibotta, Inc. and Encourages Investors to Contact the Firm
NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Ibotta, Inc. ('Ibotta' or the 'Company') (NYSE:IBTA) in the United States District Court for the District of Colorado on behalf of all persons and entities who purchased or otherwise acquired Ibotta securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Ibotta's April 18, 2024 initial public offering (the 'Class Period'). Investors have until June 16, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit. Click here to participate in the action. The Complaint alleges that in connection with the Initial Public Offering on April 18, 2024, Ibotta issued a registration statement that contained false and/or misleading statements or omissions. Specifically, the Complaint alleges that: (1) The registration statement failed to warn investors of the risks concerning Ibotta's contract with The Kroger Co. ('Kroger'); (2) Kroger's contract was at-will, and Ibotta failed to warn investors that a large client could cancel their contract with Ibotta without warning. Despite providing a detailed explanation of the terms of Ibotta's contract with another large customer, there was not a single warning of the at-will nature of Kroger's contract; (3) Rather than disclosing the very real risk of a major client walking away at any time, Ibotta provided boilerplate warnings concerning the importance of maintaining ongoing relationships with their clients; (4) By August 13, 2024, Kroger was no longer listed as a client in Ibotta's SEC filings; and (5) The price of Ibotta's securities has plummeted since the IPO, devastating investors. Currently, Ibotta stock trades significantly lower than the IPO price of $88.00 per share. If you purchased or otherwise acquired Ibotta shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Marion Passmore, Esq. (212) 355-4648 [email protected]
Associated Press
18-04-2025
- Business
- Associated Press
MERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Merck & Co., Inc. (NYSE: MRK) on behalf of long-term stockholders following a class action complaint that was filed against Merck on February 12, 2025 with a Class Period from February 3, 2022, to February 3, 2025. Our investigation concerns whether the board of directors of Merck have breached their fiduciary duties to the company. The Merck class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Merck's projected revenue outlook and anticipated growth of Gardasil while also minimizing risk from competition and drug approval development, such as China's approval to shift Gardasil to a 2-dose regimen; (ii) in truth, Merck's optimistic reports of growth, claims of successful consumer activation and education in China, overall ability to drive demand, and efforts to downplay the impact of competition on Gardasil fell short of the reality; and (iii) Merck's ability to push Gardasil in China had materially diminished. The Merck class action lawsuit further alleges that on July 30, 2024, Merck revealed that in the second quarter of 2024 'there was a significant step down in shipments from our distributor and commercialization partner, Zhifei, into the points of vaccination, compared with prior quarters, resulting in above normal inventory levels at Zhifei.' On this news, the price of Merck stock fell nearly 10%, according to the complaint. Then, on February 4, 2025, the Merck class action lawsuit alleges that Merck published its fourth quarter fiscal year 2024 results, disclosing that 'GARDASIL/GARDASIL 9 Sales Declined 3% to $8.6 Billion; Excluding the Impact of Foreign Exchange, Sales Declined 2%" 'primarily due to lower demand in China, partially offset by higher demand in most international regions, particularly in Japan.' On this news, the price of Merck stock fell more than 9%, according to the complaint. If you are a long-term stockholder of Merck, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Marion Passmore, Esq. (212) 355-4648 [email protected]
Associated Press
27-03-2025
- Business
- Associated Press
CROCS ALERT: Bragar Eagel & Squire, P.C. is Investigating Crocs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Crocs, Inc. (NASDAQ: CROX) on behalf of long-term stockholders following a class action complaint that was filed against Crocs on January 22, 2025 with a Class Period from November 3, 2022, to October 28, 2024. Our investigation concerns whether the board of directors of Crocs have breached their fiduciary duties to the company. According to the lawsuit, Defendants made misrepresentations concerning the fact that the strong revenue growth exhibited by HEYDUDE, another footwear brand Crocs acquired in February 2022, was largely driven by a conscious decision on the part of Crocs management to aggressively stock its third-party wholesaler pipeline with HEYDUDE products, regardless of the level of retail demand being experienced by those wholesalers. If you are a long-term stockholder of Crocs, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Marion Passmore, Esq.
